Pharmaceutical Analysis & Statistics in Canada, November 2014

You might be interested in: Therapeutics, Drug, Cancer, more »

1-50 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

MarketVIEW: Herpes Zoster (adult) vaccines

MarketVIEW: Herpes Zoster (adult) vaccines

  • $ 4 995
  • Industry report
  • October 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Varicella-zoster virus is a ubiquitous human alphaherpesvirus, which after infection in childhood causes a relatively mild self-limiting illness. However, if the virus becomes reactivated later on in life ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Argentina, Brazil, Mexico, Canada, Spain, Italy, France, Germany, Europe, World, United States, South America, North America
Global Chitin and Chitosan Market

Global Chitin and Chitosan Market

  • $ 4 950
  • Industry report
  • September 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Chitin and Chitosan in Metric Tons. The market for Chitin is analyzed by the following derivatives: Glucosamine, Chitosan, and Others. The market for Chitosan ...

  • Industries : Over-the-counter Drug
  • Countries : World, Japan, Canada, United States, Europe
Physiotherapy Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, Musculoskeletal) & by End Users (Hospitals), Advanced technologies - Global Forecast to 2019

Physiotherapy Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, Musculoskeletal) & by End Users (Hospitals), Advanced technologies - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

Developing markets such as Middle East, Australia, New Zealand, China, India, and Malaysia are lucrative markets for physiotherapy equipment, owing to favorable government incentives and developing healthcare ...

  • Industries : Therapy
  • Countries : World, North America, Europe, Germany, Canada, United States, China, Australia
Premature Ejaculation - Pipeline Review, H2 2014

Premature Ejaculation - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

Premature Ejaculation - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Premature Ejaculation - Pipeline Review, H2 2014', provides an overview of the Premature Ejaculation's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : World, Canada
Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2014-2019

Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2014-2019

  • $ 1 500
  • Industry report
  • September 2014
  • by Mordor Intelligence LLP

Growing numbers of farm and companion animals, increasing use of intensive animal husbandry practices and rising incidence of chronic diseases in animals have propelled the need for better animal healthcare. ...

  • Industries : Drug and Medication
  • Countries : World, France, Europe, Canada, Germany, North America, United States, India, China, Switzerland, Brazil, Mexico, Sweden, Spain, Italy, Japan
Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2014-2019

Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2014-2019

  • $ 1 500
  • Industry report
  • September 2014
  • by Mordor Intelligence LLP

Global market for veterinary anti-infectives is estimated to be worth $4.37 billion in 2014. Expected to grow at a healthy CAGR of 8.5%, the market is set to reach $6.92 billion by 2019. For the past several ...

  • Industries : Drug and Medication
  • Countries : World, France, Canada, Germany, Europe, United States, North America, Switzerland, Mexico, Sweden, Spain, Italy, Japan, India, China
North America Anticoccidial Drugs Market - Global Trends And Forecasts - (2014-19)

North America Anticoccidial Drugs Market - Global Trends And Forecasts - (2014-19)

  • $ 1 500
  • Industry report
  • August 2014
  • by Mordor Intelligence LLP

North American countries combined contribute around 24% of the global market for anticoccidial drugs. The demand for anticoccidial drugs is expected to grow by CAGR of 3.4 percent in terms of revenues ...

  • Industries : Drug and Medication
  • Countries : North America, United States, World, Mexico, Canada
Canada Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Canada Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: The Canadian pharmaceutical industry continues to be a refuge for leading drugmakers. While we foresee cost constraints hitting the public healthcare system, it is highly unlikely the government ...

  • Industries : Drug and Medication
  • Countries : Canada
Anti-Infective Drug News 06 OCTOBER 2014

Anti-Infective Drug News 06 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Gilead Acts To Secure Its Reign Over HIV-1 Market Industry Brief - Vibativ Now Available In Europe For HAP/VAP Industry Brief - FDA Grants Fast Track Designation For MEDI3902 ...

  • Industries : Drug and Medication
  • Countries : Japan, Canada
Cancer Drug News 29 SEPTEMBER 2014

Cancer Drug News 29 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Amgen Vies For Swift Blinatumomab Approval Industry Brief - TG Agrees SPA With FDA For CLL Phase III Trial Industry Brief - Cephalon Acts To End Litigation Against Eagle Industry ...

  • Industries : Drug and Medication
  • Countries : China, Canada, United Kingdom
CNS Drug News 15 SEPTEMBER 2014

CNS Drug News 15 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - FDA-Approved Contrave Enters Tough And Competitive Market Industry Trend Analysis - Nuplazid's FDA Breakthrough Therapy Designation Boosts ACADIA Industry Brief - Phase IIa Study ...

  • Industries : Drug and Medication
  • Countries : United States, Canada, Japan
Cancer Drug News 15 SEPTEMBER 2014

Cancer Drug News 15 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Boom In Antibody-Drug Conjugate Market On The Horizon Industry Brief - First Patient Dosed In Phase II Study Of Lucitanib In Advanced BC Industry Trend Analysis - SGX301 Has Potential ...

  • Industries : Drug and Medication
  • Countries : Canada, Japan, United States, Sweden, China, World
Drug Delivery Insight 15 SEPTEMBER 2014

Drug Delivery Insight 15 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Teva Victory Over AstraZeneca Overshadowed By Fierce Respiratory Competition Industry Brief - Clearside Closes Series B Funding Industry Brief - Pinnacle/Orphan Canada Collaborate ...

  • Industries : Drug Delivery Technology
  • Countries : Canada, United States
GeneNews Limited (GEN) - Product Pipeline Analysis, 2014 Update

GeneNews Limited (GEN) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • October 2014
  • by Global Data

Summary GeneNews Limited (GeneNews) is a cancer diagnostics company. The company develops, licenses and commercializes genomic-based clinical laboratory tests. It develops diagnostic tests such as, ColonSentry ...

  • Industries : Pathology
  • Countries : United States, Canada
Proof Centre of Excellence - Product Pipeline Analysis, 2014 Update

Proof Centre of Excellence - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary Proof Centre of Excellence (PROOF Centre) is a healthcare organization. The organization develops blood tests and platforms to predict, diagnose, manage and treat heart, lung and kidney diseases. ...

  • Industries : Pathology
  • Countries : Canada
MicroVention, Inc. - Product Pipeline Analysis, 2014 Update

MicroVention, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary MicroVention, Inc. (MicroVention) is a medical device company. The company develops catheter based technologies for the endovascular treatment of peripheral and cerebral vascular diseases. Its ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Costa Rica, North America, Canada, France, Germany, Japan
Medical International Technology, Inc. (MDLH) - Product Pipeline Analysis, 2014 Update

Medical International Technology, Inc. (MDLH) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary Medical International Technologies (Mit Canada) Inc. (MIT) is a medical device manufacturer. The company develops, manufactures and markets needle free jet injectors for veterinary and human applications. ...

  • Industries : Drug Delivery Technology
  • Countries : Canada, China
Abacavir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Abacavir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Acitretin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Acitretin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Adefovir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Adefovir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Armodafinil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Armodafinil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Atovaquone  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Atovaquone - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Brinzolamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Brinzolamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Caspofungin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Caspofungin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Celecoxib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Celecoxib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Duloxetine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Duloxetine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Dutasteride  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Dutasteride - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Frovatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Frovatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Galantamine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Galantamine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
About 1 800 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Canada - Forecast

  • 21 September to 4 October, 2014 (weeks 39 & 40)
  • October 2014
    10 pages
  • Influenza  

  • Canada  

    North America  

View report >

6 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.